Why Dolby Laboratories, Inc.’s (DLB) Stock Is Up 12.91%
As of Friday, July 31, Dolby Laboratories, Inc.’s DLB share price has surged by 12.91%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
Commentary & Analysis
Why Dolby Laboratories, Inc.’s (DLB) Stock Is Up 11.57%
As of Friday, July 31, Dolby Laboratories, Inc.’s DLB share price has surged by 11.57%, which has investors questioning if this is right time to sell.Omar Beirat
Is Dolby Laboratories, Inc. (DLB) Overvalued?
We dive into why Dolby Laboratories, Inc. (DLB) could be considered overvalued on 2026-07-29, based on AAII’s Value Score and Grade.Tudor Pop
Which Is a Better Investment, Dolby Laboratories, Inc. or Karooooo Ltd. Stock?
Learn more about whether Dolby Laboratories, Inc. or Karooooo Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Michael Rose
Which Is a Better Investment, Arteris, Inc. or Dolby Laboratories, Inc. Stock?
Learn more about whether Arteris, Inc. or Dolby Laboratories, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Rosalio Madrigal
Financial Summary
| Share Statistics | DLB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5,508.7 | $977.4 | 69% |
|
| Shares Out (Mil) | 94.5 | 78.1 | 61% |
|
| Institutional Ownership | 97.5% | 79.0% | 74% |
|
| Float (Mil) | 59.7 | 57.6 | 51% |
|
| Beta | 0.81 | 1.03 | 48% |
|
| Avg Daily Volume (000s) | 995 | 750 | 70% |
|
| Price Change (52-week) |
(22.3%) | 56.5% | 29% |
|
| Growth | DLB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 3.0% | 14.8% | 27% |
|
| Net Income (5yr) | 2.0% | 10.1% | 42% |
|
| EPS (5yr) | 3.1% | 16.2% | 35 |
|
| Dividends (5yr) | 8.9% | 0.0% | 85% |
|
| Cash Flow (5yr) | (3.8%) | (15.3%) | 62% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 3 | 3 | |
| Current EPS | $0.670 | $4.327 | $4.597 | |
| Month Ago EPS | $0.670 | $4.320 | $4.603 | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 2 | 1 | 0 | |
| Three Months Ago EPS | $0.670 | $4.310 | $4.603 | |
| Year/Year Chg | 123.3% | 65.2% | 94.7% | |
| Financials | DLB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,354 | $348 | 55% |
|
| Net Income (TTM) (Mil) | $226 | ($2) | 70% |
|
| EPS (TTM) | $2.377 | ($0.100) | 75% |
|
| Operating Cash Flow (TTM) (Mil) | $438 | $30 | 70% |
|
| Net Cash Flow (TTM) (Mil) | ($18) | $0 | 27% |
|
| Long-Term Debt (Q1) (Mil) | $38 | $35 | 37% |
|
| Enterprise Value (Q1) (Mil) | $4,285 | $1,019 | 60% |
|
| Valuation | DLB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.13 | 3.24 | 53% |
|
| P/E | 25.0 | 34.8 | 61% |
|
| Dividend Yield | 2.4% | 0.0% | 79% |
|
| PEG (5yr hist) | 8.1 | 2.1 | 92% |
|
| Ratios | DLB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 87.6% | 70.5% | 93% |
|
| Net Margin | 16.7% | 0.6% | 75% |
|
| ROA | 7.1% | (1.6%) | 80% |
|
| ROE | 8.7% | 1.6% | 54% |
|
| Liabilities to Assets | 17.9% | 46.1% | 11% |
|
| F-Score | 5 | 5 | 51% |
|
Dolby Laboratories, Inc. did not pass any screens on 7/31/2026.
